Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/CIA.S50819 http://scihub22266oqcxt.onion/10.2147/CIA.S50819 C4467644!4467644!26089654     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Interv+Aging 2015 ; 10 (ä): 931-7 Nephropedia Template TP {{tp|p=26089654|t=2015. Zonisamide in the management of epilepsy in the elderly |pdf=|usr=}}{{26089654}} gab.com Text Zonisamide in the management of epilepsy in the elderly JO: Clin Interv Aging http://www.kidney.de/pget.php?&tw=1&pmid=26089654 #FOAvip Zonisamide (ZNS), a second-generation antiepileptic drug, indicated as add-on treatment of focal epilepsy, has been recently approved as monotherapy for the treatment of partial seizures in adults affected by newly diagnosed epilepsy in Europe. Evidence on the efficacy and tolerability of antiepileptic drugs in the elderly is still lacking as these patients are frequently excluded from clinical trials. Here, a comprehensive overview of available data regarding the use of ZNS in the treatment of epilepsy in elderly people is provided. In a pooled analysis conducted in patients aged ?65 years, no new/unexpected safety findings have emerged. Few data from uncontrolled investigations suggest that ZNS may be effective and well tolerated when administered as monotherapy or adjunctive antiepileptic treatment in the elderly. However, evidence from these observational studies is less than satisfactory, and randomized controlled trials focused on these patients are still needed. Twit Text FOAVip Zonisamide in the management of epilepsy in the elderly ????Clin Interv Aging http://www.kidney.de/pget.php?&tw=1&pmid=26089654 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26089654 #FOAvip English Wikipedia <ref>{{Cite pmid|26089654}}</ref> Zonisamide in the management of epilepsy in the elderly #MMPMID26089654 Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V Clin Interv Aging 2015[]; 10 (ä): 931-7 PMID26089654show ga Zonisamide (ZNS), a second-generation antiepileptic drug, indicated as add-on treatment of focal epilepsy, has been recently approved as monotherapy for the treatment of partial seizures in adults affected by newly diagnosed epilepsy in Europe. Evidence on the efficacy and tolerability of antiepileptic drugs in the elderly is still lacking as these patients are frequently excluded from clinical trials. Here, a comprehensive overview of available data regarding the use of ZNS in the treatment of epilepsy in elderly people is provided. In a pooled analysis conducted in patients aged ?65 years, no new/unexpected safety findings have emerged. Few data from uncontrolled investigations suggest that ZNS may be effective and well tolerated when administered as monotherapy or adjunctive antiepileptic treatment in the elderly. However, evidence from these observational studies is less than satisfactory, and randomized controlled trials focused on these patients are still needed. äZonisamide in the management of epilepsy in the elderly (epmc).pdf DeepDyve Pubget Overpricing